NCT05834088

Brief Summary

Dysperunia is caused by chronic discomfort during sexual intercourse causing pain during vaginal intercourse.Sexual pain causes relationship decreasing quality of life following anxiety and depression.Myofascial techniques with and without Thiele massage will be used via randomised controlled trial following sample size of 38.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 18, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 28, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2023

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
Last Updated

June 13, 2024

Status Verified

June 1, 2024

Enrollment Period

8 months

First QC Date

April 18, 2023

Last Update Submit

June 11, 2024

Conditions

Keywords

DyspareuniaPelvic floor disorderPelvic painMyofascial release techniquePelvic floor

Outcome Measures

Primary Outcomes (3)

  • Numeric pain rating scale

    The numeric rating scale (NRS) is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable".

    12 weeks

  • Female sexual function index

    The FSFI is a widely-used measure of Female Sexual Dysfunction (FSD). It assesses 6 domains: desire; arousal; lubrication; orgasm; satisfaction; and pain.

    12 weeks

  • Functional pelvic pain scale

    Functional Pelvic Pain Scale (FPPS), designed to measure pelvic pain intensity as it relates to functions of daily living (bladder and bowel function, intercourse, walking, running, lifting, working, and sleeping).

    12 weeks

Study Arms (2)

Myofascial techniques with Thiele massage

EXPERIMENTAL

Group A will receive myofascial techniques with Thiele massage. 12 treatment sessions will be given in 12 weeks

Other: Myofascial release techniquesOther: Thiele massage

Myofascial techniques without Thiele massage

ACTIVE COMPARATOR

Group B will receive myofascial techniques without Thiele massage. 12 treatment sessions will be given in 12 weeks

Other: Myofascial release techniques

Interventions

12 treatment sessions will be given in 12 weeks

Myofascial techniques with Thiele massageMyofascial techniques without Thiele massage

12 treatment sessions will be given in 12 weeks

Myofascial techniques with Thiele massage

Eligibility Criteria

Age23 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsNulliparous females
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 23-40
  • Dyspareunia symptoms for more than 6 months
  • Females with tenderness of pelvic muscles from last 6 months
  • Nulliparous women

You may not qualify if:

  • Any pelvic organ prolapse
  • Any current genital malignancy
  • Cases of chronic pelvic pain due to any other issue
  • Any traumatic conditions around the pelvis and lower limbs, any infectious, tumors conditions around the pelvis.
  • Pregnant females
  • Any lower limb abnormalities, any recently underwent abdominal and low back surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jinnah hospital

Lahore, Punjab Province, 54000, Pakistan

Location

Related Publications (6)

  • Mitchell KR, Geary R, Graham CA, Datta J, Wellings K, Sonnenberg P, Field N, Nunns D, Bancroft J, Jones KG, Johnson AM, Mercer CH. Painful sex (dyspareunia) in women: prevalence and associated factors in a British population probability survey. BJOG. 2017 Oct;124(11):1689-1697. doi: 10.1111/1471-0528.14518. Epub 2017 Jan 25.

    PMID: 28120373BACKGROUND
  • Tayyeb M, Gupta V. Dyspareunia. 2023 Jun 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK562159/

    PMID: 32965830BACKGROUND
  • Castellanos-Lopez E, Castillo-Merino C, Abuin-Porras V, Lopez-Lopez D, Romero-Morales C. Ultrasonography Comparison of Pelvic Floor and Abdominal Wall Muscles in Women with and without Dyspareunia: A Cross-Sectional Study. Diagnostics (Basel). 2022 Jul 29;12(8):1827. doi: 10.3390/diagnostics12081827.

    PMID: 36010178BACKGROUND
  • Rosen NO, Dawson SJ, Binik YM, Pierce M, Brooks M, Pukall C, Chorney J, Snelgrove-Clarke E, George R. Trajectories of Dyspareunia From Pregnancy to 24 Months Postpartum. Obstet Gynecol. 2022 Mar 1;139(3):391-399. doi: 10.1097/AOG.0000000000004662.

    PMID: 35115480BACKGROUND
  • Alimi Y, Iwanaga J, Oskouian RJ, Loukas M, Tubbs RS. The clinical anatomy of dyspareunia: A review. Clin Anat. 2018 Oct;31(7):1013-1017. doi: 10.1002/ca.23250. Epub 2018 Oct 26.

    PMID: 30113086BACKGROUND
  • Geller EJ, Babb E, Nackley AG, Zolnoun D. Incidence and Risk Factors for Pelvic Pain After Mesh Implant Surgery for the Treatment of Pelvic Floor Disorders. J Minim Invasive Gynecol. 2017 Jan 1;24(1):67-73. doi: 10.1016/j.jmig.2016.10.001. Epub 2016 Oct 20.

    PMID: 27773810BACKGROUND

MeSH Terms

Conditions

DyspareuniaPainPelvic Floor DisordersPelvic Pain

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGenital Diseases, MaleSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPregnancy Complications

Study Officials

  • Sabiha Arshad, M.phil

    Riphah International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 18, 2023

First Posted

April 28, 2023

Study Start

November 20, 2022

Primary Completion

July 30, 2023

Study Completion

August 1, 2023

Last Updated

June 13, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations